HES1 and colorectal cancer: Unlike oxaliplatin, these complexes do not enhance the expression of HES-1, a crucial gene in the Notch signaling pathway implicated in colorectal cancer self-renewal and tumorigenicity, suggesting they may disrupt the signaling mechanisms supporting cancer stemness [41].